Charles M. Baum - 17 Jun 2024 Form 4 Insider Report for Poseida Therapeutics, Inc. (PSTX)

Role
Director
Signature
/s/ Harry J.Leonhardt, Attorney-in-Fact
Issuer symbol
PSTX
Transactions as of
17 Jun 2024
Transactions value $
$0
Form type
4
Date filed
18 Jun 2024, 16:13
Previous filing
10 Jun 2024
Next filing
24 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PSTX Common Stock Award $0 +19.7K +33.33% $0.00 78.6K 17 Jun 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PSTX Stock Option (Right to buy) Award $0 +27.4K $0.00 27.4K 17 Jun 2024 Common Stock 27.4K $2.81 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units granted pursuant to the Issuer's Equity Incentive Plan. The RSUs are scheduled to vest on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders.
F2 The stock option will vest and become fully exercisable on the earlier to occur of (i) the one year anniversary of the date of grant and (ii) the day preceding the date of the next annual meeting of the Issuer's stockholders.